It's also fully consistent with our capital allocation priorities to drive attractive returns for shareholders, underpinned by a strong investment grade balance sheet." The Company will make a further announcement upon completion of the off-market purchase. Amanda Mellor Company Secretary Enquiries About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.